Evidence map›Paper›PMID 25760600›Full record

ArticleActa crystallographica. Section D, Biological crystallography2015

A disulfide-bond cascade mechanism for arsenic(III) S-adenosylmethionine methyltransferase.

Kavitha Marapakala, Charles Packianathan, A Abdul Ajees, Dharmendra S Dheeman, Banumathi Sankaran, Palani Kandavelu, Barry P Rosen

Open access · bronzeAbstract read
In one paragraph

Article in Acta crystallographica. Section D, Biological crystallography, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 50 citations in OpenAlex.

  1. Growth substrate limitation enhances anaerobic arsenic methylation byApplied and environmental microbiology · 2024
    Article
  2. Article
  3. Article
  4. Bifunctional protein ArsRBMC microbiology · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Kavitha MarapakalaDepartment of Chemistry, Osmania University College for Women, Osmania University, Hyderabad 500 095, India.
Charles PackianathanDepartment of Cellular Biology and Pharmacology, Florida International University Herbert Wertheim College of Medicine, 11200 S. W. 8th Street, Miami, FL 33199, USA.
A Abdul AjeesDepartment of Atomic and Molecular Physics, Manipal Institute of Technology, Manipal University, Manipal, Karnataka 576 104, India.
Dharmendra S DheemanDepartment of Cellular Biology and Pharmacology, Florida International University Herbert Wertheim College of Medicine, 11200 S. W. 8th Street, Miami, FL 33199, USA.
Banumathi SankaranPhysical Biosciences Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94702, USA.
Palani KandaveluSER-CAT and the Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
Barry P RosenDepartment of Cellular Biology and Pharmacology, Florida International University Herbert Wertheim College of Medicine, 11200 S. W. 8th Street, Miami, FL 33199, USA.
Florida International University · USLawrence Berkeley National Laboratory · USManipal Academy of Higher Education · INOsmania University · INUniversity of Georgia · US

Funding

Mechanisms of arsenical transportR37GM055425 · NIGMS · WAYNE STATE UNIVERSITY · PI ROSEN, BARRY P. · 2005 to 2014
$4.4M
NIGMS NIH HHS R37 GM055425NIGMS NIH HHS R37 GM55425
6 · The paper itself

Abstract

Methylation of the toxic metalloid arsenic is widespread in nature. Members of every kingdom have arsenic(III) S-adenosylmethionine (SAM) methyltransferase enzymes, which are termed ArsM in microbes and AS3MT in animals, including humans. Trivalent arsenic(III) is methylated up to three times to form methylarsenite [MAs(III)], dimethylarsenite [DMAs(III)] and the volatile trimethylarsine [TMAs(III)]. In microbes, arsenic methylation is a detoxification process. In humans, MAs(III) and DMAs(III) are more toxic and carcinogenic than either inorganic arsenate or arsenite. Here, new crystal structures are reported of ArsM from the thermophilic eukaryotic alga Cyanidioschyzon sp. 5508 (CmArsM) with the bound aromatic arsenicals phenylarsenite [PhAs(III)] at 1.80 Å resolution and reduced roxarsone [Rox(III)] at 2.25 Å resolution. These organoarsenicals are bound to two of four conserved cysteine residues: Cys174 and Cys224. The electron density extends the structure to include a newly identified conserved cysteine residue, Cys44, which is disulfide-bonded to the fourth conserved cysteine residue, Cys72. A second disulfide bond between Cys72 and Cys174 had been observed previously in a structure with bound SAM. The loop containing Cys44 and Cys72 shifts by nearly 6.5 Å in the arsenic(III)-bound structures compared with the SAM-bound structure, which suggests that this movement leads to formation of the Cys72-Cys174 disulfide bond. A model is proposed for the catalytic mechanism of arsenic(III) SAM methyltransferases in which a disulfide-bond cascade maintains the products in the trivalent state.

Indexed as

ArsenatesCysteineDisulfidesMethyltransferasesPlant ProteinsProtein Structure, SecondaryProtein Structure, TertiaryRhodophytaArsenatesarsenic acidCysteineDisulfidesMethyltransferasesPlant Proteinsarsenic(III) S-adenosylmethionine methyltransferaseAS3MTdisulfide-bond cascadephenylarseniteroxarsone

Identifiers

PMID25760600
PMCPMC4356363
OpenAlexW2004472256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.